Literature DB >> 27190840

Testing of Hypothesis in Equivalence and Non Inferiority Trials-A Concept.

Atul Juneja1, Abha R Aggarwal2, Tulsi Adhikari1, Arvind Pandey3.   

Abstract

Establishing the appropriate hypothesis is one of the important steps for carrying out the statistical tests/analysis. Its understanding is important for interpreting the results of statistical analysis. The current communication attempts to provide the concept of testing of hypothesis in non inferiority and equivalence trials, where the null hypothesis is just reverse of what is set up for conventional superiority trials. It is similarly looked for rejection for establishing the fact the researcher is intending to prove. It is important to mention that equivalence or non inferiority cannot be proved by accepting the null hypothesis of no difference. Hence, establishing the appropriate statistical hypothesis is extremely important to arrive at meaningful conclusion for the set objectives in research.

Keywords:  Equivalence trials; Statistical hypothesis

Year:  2016        PMID: 27190840      PMCID: PMC4866138          DOI: 10.7860/JCDR/2016/17748.7547

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  3 in total

1.  Current issues in clinical equivalence trials.

Authors:  W C Blackwelder
Journal:  J Dent Res       Date:  2004       Impact factor: 6.116

2.  Sample size requirements for evaluating a conservative therapy.

Authors:  R Makuch; R Simon
Journal:  Cancer Treat Rep       Date:  1978-07

3.  P value and the theory of hypothesis testing: an explanation for new researchers.

Authors:  David Jean Biau; Brigitte M Jolles; Raphaël Porcher
Journal:  Clin Orthop Relat Res       Date:  2010-03       Impact factor: 4.176

  3 in total
  1 in total

1.  Comparison of morning vs bedtime administration of the combination of valsartan/amlodipine on nocturnal brachial and central blood pressure in patients with hypertension.

Authors:  Takeshi Fujiwara; Satoshi Hoshide; Yuichiro Yano; Hiroshi Kanegae; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-11-05       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.